Yue Xizan, Liu Bo, Han Tiantian, Luo Ningning, Lu Guanghua, Guo Didi, Bu Fanfeng, Wang Guangyu
Department of Neurosurgery, Qilu Children's Hospital of Shandong University, Jinan, China.
The Medical Department, Jiangsu Simcere Diagnostics Co., Ltd., Nanjing, China.
Front Oncol. 2022 May 16;12:835220. doi: 10.3389/fonc.2022.835220. eCollection 2022.
Central nervous system germ cell tumors (CNS GCTs) are a heterogeneous group of primary CNS tumors. GCTs are more common and mostly observed in pediatric and young adult patients. CNS GCTs are divided into germinomas and non-germinomatous germ cell tumors (NGGCTs), with different therapeutic strategies depending on diagnosis. Herein, we report a patient with pediatric central nervous system germinoma harboring a somatic p.Y823D and a heterozygous germline p. T396Nfs*14 mutation detected by next generation sequencing. After surgery, the patient received chemotherapy (temozolomide + nedaplatin + etoposide). This is the first report of a Chinese pediatric patient with CNS GCT harboring concurrent germline and somatic mutation, which enriches molecular profiles of CNS GCTs and provides more molecular evidence of clinical diagnosis and potential targeted therapy in CNS GCTs.
中枢神经系统生殖细胞肿瘤(CNS GCTs)是一组异质性的原发性中枢神经系统肿瘤。生殖细胞肿瘤较为常见,主要见于儿童和年轻成年患者。CNS GCTs分为生殖细胞瘤和非生殖细胞性生殖细胞肿瘤(NGGCTs),根据诊断不同采取不同的治疗策略。在此,我们报告1例患有小儿中枢神经系统生殖细胞瘤的患者,通过下一代测序检测到一个体细胞p.Y823D和一个杂合种系p.T396Nfs*14突变。手术后,该患者接受了化疗(替莫唑胺+奈达铂+依托泊苷)。这是首例关于中国小儿CNS GCT患者同时存在种系和体细胞突变的报告,丰富了CNS GCTs的分子图谱,并为CNS GCTs的临床诊断和潜在靶向治疗提供了更多分子证据。